Concord Wealth Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1
Closed 1328
2022
Q1
$0 Sell
1
-12
-92% ﹤0.01% 1350
2021
Q4
$3K Buy
13
+1
+8% +$231 ﹤0.01% 1068
2021
Q3
$3K Buy
12
+4
+50% +$1K ﹤0.01% 700
2021
Q2
$2K Buy
8
+5
+167% +$1.25K ﹤0.01% 903
2021
Q1
$1K Buy
+3
New +$1K ﹤0.01% 933